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AbstrACt
Objectives To develop new nomograms by adding ECG 
changes (ST depression or tall T wave) and age to three 
conventional scoring systems, namely, World Federation 
of Neurosurgical Societies (WFNS) scale, Hunt and Hess 
(HH) system and Fisher scale, that can predict prognosis 
in patients with subarachnoid haemorrhage (SAH) using 
our preliminary research results and to perform external 
validation of the three new nomograms.
Design Retrospective, observational study
setting Emergency departments (ED) of two university-
affiliated tertiary hospital between January 2009 and 
March 2015.
Participants Adult patients with SAH were enrolled. 
Exclusion criteria were age <19 years, no baseline ECG, 
cardiac arrest on arrival, traumatic SAH, referral from other 
hospital and referral to other hospitals from the ED.
Primary outcome measures The 6 month prognosis was 
assessed using the Glasgow Outcome Scale (GOS). We 
defined a poor outcome as a GOS score of 1, 2 or 3.
results A total of 202 patients were included for analysis. 
From the preliminary study, age, ECG changes (ST 
depression or tall T wave), and three conventional scoring 
systems were selected to predict prognosis in patients 
with SAH using multi-variable logistic regression. We 
developed simplified nomograms using these variables. 
Discrimination of the developed nomograms including 
WFNS scale, HH system and Fisher scale was superior to 
those of WFNS scale, HH system and Fisher scale (0.912 
vs 0.813; p<0.001, 0.913 vs 0.826; p<0.001, and 0.885 
vs 0.746; p<0.001, respectively). The calibration plots 
showed excellent agreement. In the external validation, 
the discrimination of the newly developed nomograms 
incorporating the three scoring systems was also good, 
with an area under the receiver-operating characteristic 
curve value of 0.809, 0.812 and 0.772, respectively.
Conclusions We developed and externally validated new 
nomograms using only three independent variables. Our 
new nomograms were superior to the WFNS scale, HH 
systems, and Fisher scale in predicting prognosis and are 
readily available.
IntrODuCtIOn 
Subarachnoid haemorrhage (SAH) is 
defined as haemorrhage in the subarach-
noid space, and the reported incidence is 
9–11 per 100 000 person years worldwide.1 
SAH accounts for 4% of all cerebrovascular 
diseases and develops at a relatively young 
age, with approximately 50% of patients 
experiencing disability or death.2 Because 
of the high mortality and low recovery rate, 
predicting prognosis in patients with SAH 
is crucial.1–3 Botterell et al presented the 
first grading system for SAH in 1956,4 and 
different systems have since been developed. 
strengths and limitations of this study
 ► Our nomograms are the first to combine ECG chang-
es and other prognostic factors in patients with sub-
arachnoid haemorrhage.
 ► Our nomogramsare solely based on ECG changes, 
age and conventional scoring systems, which are 
easily and readily obtainable during the patient’s 
course in the ED.
 ► Because this study is a retrospective, observational 
study, the predictive probability could be overesti-
mated more than in a prospective study.
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The Hunt and Hess (HH) system, the World Federation 
of Neurosurgical Societies (WFNS) scale and the Fisher 
scale have been widely used globally.5–7 These three 
systems are simple but do not include clinically important 
factors, such as comorbidity, age and vital signs on admis-
sion, and differences between the grades for each system 
are ambiguous. A range of scoring scales has been devel-
oped to overcome the limitations of the existing scoring 
scales.5–10 
Factors such as age, past medical history (hyperten-
sion, diabetes mellitus, history of brain disease), blood 
pressure and initial level of consciousness on admis-
sion and cerebral aneurysm size have been reported to 
be independently associated with prognosis of patients 
with SAH.8 11ECG abnormalities have also been studied 
as a prognostic factor. ECG abnormalities are observed 
in 40%–90% of patients with SAH12–14 and have been 
associated with hyperactivity of the sympathetic nervous 
system due to autonomic nervous system dysregulation.15 
Since the hyperactivity of the sympathetic nerve reflects 
the degree of cerebral haemorrhage, ECG changes may 
be associated with patient prognosis. The most common 
reported abnormalities are QT prolongation, ST segment 
changes and T wave abnormalities.15 16 A number of studies 
have investigated the prognostic value of ECG abnormali-
ties.17 18 However, the role of an abnormal ECG as a prog-
nostic predictor remains debatable. QTc changes and 
ST segment changes have been reported as the param-
eters most significantly associated with prognosis,17 19 
although further studies reported no significant associa-
tion between ECG change and outcome.12 14 19 Because 
of this uncertainty, the existing system for predicting the 
prognosis of patients with SAH does not include ECG 
changes as a prognostic variable. However, ECG is an 
inexpensive test that is readily available in an emergency 
setting. Because accelerated sympathetic activity reaches 
its climax in the first 24 hours after the onset of SAH, ECG 
abnormalities develop during the early stage of disease, 
disappearing over time.13 15 16 Therefore, it is important to 
consider ECG changes as an initial prognostic factor. We 
conducted preliminary research to investigate the asso-
ciation between the above-mentioned prognostic factors, 
including ECG changes, and prognosis of patients with 
SAH and found that age, ECG changes and the three 
scoring systems were associated with patient prognosis.20
Among the computational models for predicting 
prognosis, the nomogram is very useful because it is 
a pictorial representation of a statistical predictive 
model that generates a numerical probability of a clin-
ical event. It is more accurate than the conventional 
method using OR.21 Therefore, the objective of this 
study was to develop new nomograms that can predict 
prognosis of patients with SAH using the results of 
our preliminary research and to perform external 
validation of the new nomograms.
MAterIAls AnD MethODs
study design and populations
We performed a retrospective, observational study to 
develop new nomograms that can predict prognosis of 
patients with SAH and to perform external validation 
of the new nomograms. This study was conducted on 
two independent cohorts of patients with SAH from 
two hospitals. We enrolled patients with SAH diag-
nosed by brain CT or xanthochromia of the cerebro-
spinal fluid in the emergency department (ED) of 
Severance Hospital between January 2009 and March 
2015 as primary cohort. Exclusion criteria were as 
follows: (1) age less than 19 years; (2) administration 
of a cardiovascular drug, such as calcium-channel 
blockers, with no baseline ECG; (3) cardiac arrest on 
arrival; and (4) traumatic SAH. Additionally, patients 
were excluded if they were referred from other hospi-
tals because initial ECG could not be obtained and 
patients were often treated with medication affecting 
the cardiovascular system. Patients referred to other 
hospitals from the ED were also excluded as their 
prognosis could not be evaluated. For model external 
validation, 141 patients with SAH were enrolled in 
another ED of Gangnam Severance Hospital between 
January 2011 and December 2014 in accordance with 
the inclusion and exclusion criteria. We collected 
Figure 1 Flow diagram of the study subjects. ED, emergency department.
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sufficient data to score all variables in the established 
nomogram.
Patient and public involvement
Patients and public were not involved in the development 
of the research questions or in the design of the study 
because of its retrospective nature.
Data collection
One investigator (J.YH) retrospectively collected the data 
through a review of the medical records. We collected 
demographic data, vital signs on admission and past 
medical history, including a history of hypertension, 
diabetes mellitus and cardiovascular and cerebrovas-
cular diseases. The Glasgow Coma Scale (GCS), HH and 
WFNS scores were obtained from assessing the neurolog-
ical abnormality and the level of consciousness. Patient 
outcome was assessed using the Glasgow Outcome Scale 
(GOS) by one emergency physician blinded to the ECG 
findings. The amount of blood, the location and size of 
cerebral aneurysm and the presence or absence of intra-
ventricular haemorrhage and intracerebral haemor-
rhage were determined based on CT scans reported by 
board-certified radiologist. ECG findings were assessed 
by another emergency physician blinded to patient prog-
nosis using the Marquette Universal System of Electro-
cardiography (MUSE, GE Healthcare, Milwaukee, USA). 
Abnormal ECG findings were classified into four groups: 
ST elevation, ST depression, T wave inversion and tall 
T wave. ST elevation was defined as ≥0.1 mV elevation 
in at least two contiguous leads other than leads V2–
V3. For leads V2–V3, the following cut-off points were 
applied: ≥0.2 mV in men ≥40 years, ≥0.25 mV in men <40 
Table 1 Clinical characteristics of study populations
Good outcome Poor outcome Total
P value(n=111) (n=91) (n=202)
Age (year) 53.7 (12.3) 61.1 (13.7) 57.0 (13.4) <0.001
Sex, male 36 (32.4%) 36 (39.6%) 72 (35.6%) 0.305
Vital signs
  Systolic blood pressure (mm Hg) 154.5 (29.3) 169.6 (41.0) 154.5 (35.7) 0.003
  Heart rate (/min) 80.5 (17.5) 84.7 (22.1) 82.4 (19.8) 0.137
  Respiratory rate (/min) 15.5 (2.2) 16.7 (6.0) 16 (4.3) 0.072
  Body temperature (℃) 36.4 (0.5) 36.3 (0.7) 36.4 (0.6) 0.123
Chronic comorbidities
  Hypertension 32 (28.8%) 43 (47.3%) 75 (37.1%) 0.007
  Diabetes mellitus 7 (6.3%) 9 (9.9%) 16 (7.9%) 0.435
  Cerebrovascular accident 5 (4.5%) 3 (3.3%) 8 (4.0%) 0.516
CT findings
  Aneurysmal SAH 87 (88.4%) 61 (67.0%) 148 (73.3%) 0.227
  Posterior circulation aneurysm 23 (20.7%) 18 (19.8%) 41 (20.3%) 0.178
  Aneurysm sizes (mm) 4.0 (3.2) 4.6 (4.9) 4.3 (4.0) 0.258
  Intracerebral haemorrhage 7 (6.3%) 26 (28.6%) 33 (16.3%) <0.001
  Intraventricular haemorrhage 17 (15.3%) 41 (45.1%) 58 (28.7%) <0.001
ECG changes
  ST elevation 6 (5.4%) 11 (12.1%) 17 (8.4%) 0.125
  ST depression 2 (1.8%) 29 (31.9%) 31 (15.3%) <0.001
  T wave inversion 11 (9.9%) 10 (11%) 21 (10.4%) 0.821
  Tall T wave 1 (1%) 9 (9.9%) 10 (5.0%) 0.006
  QTc (msec) 458.1 (39.1) 479.1 (53.0) 467.6 (46.9) 0.002
Scoring systems*
  WFNS scales 1 (1~1) 4 (2~5) 2 (1~4) <0.001
  HH system 2 (2~2) 4 (3~5) 3 (2~4) <0.001
  Fisher grade 3 (3~3) 4 (3~4) 3 (3~4) <0.001
Data are presented as frequencies (%) or mean (SD), unless otherwise indicated.
*median (IQR).
HH, Hunt and Hess; SAH, subarachnoid haemorrhage; WFNS, World Federation of Neurosurgical Societies.
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years or ≥0.15 mV in women. ST depression was defined 
as ≥0.05 mV depression in all leads. An inverted T wave 
was defined as less than 0.1 mV from the baseline, and a 
tall T wave was defined as greater than 1 mV in depth.19 
QTc was redefined and measured based on heart rate 
and was adjusted using Bazett’s formula. There were no 
missing data except initial ECG because all variables used 
were collected in usual practice. The primary outcome 
of this study was assessed at 6 months after disease onset 
using GOS. We defined a poor outcome as a GOS score 
of 1, 2 or 3.
Data analysis
Statistical analysis was performed using SAS (V.9.2) and 
R package (V.3.1.3, http://www. R- project. org). The 
sample size was calculated on the basis of the area under 
the receiver-operating characteristic curve (AUC) of the 
nomogram. A difference of 0.1 between the conventional 
scoring system with an AUC of 0.78 and new nomogram 
with an AUC of 0.88 was selected as the minimum clin-
ically significant value. We assumed that the allocation 
ratio of good and poor outcome group was 4.5 to 5.5. 
The correlation between the two predictive models was 
assumed to be 0.5. We estimated that a sample size of 
183 patients would be sufficient to evaluate the primary 
outcome at a significance level of 0.05 (two-sided) with 
80% power. The sample size of the external validation 
cohort was determined to be about 70% of the sample 
size of the primary cohort.
Categorical variables were described as frequencies (%). 
Parametric data are presented as mean (SD) and non-para-
metric data are presented as the median and IQR. We 
used the independent t-test for comparison of two groups 
distributed normally, whereas the Mann–Whitney U test 
was used for the comparison of two groups that were not 
distributed normally. Fisher’s exact test was used for cate-
gorical variables. From the preliminary study, age, ECG 
changes (ST depression or tall T wave) and three conven-
tional scoring systems such as WFNS scale, HH system 
and Fisher scale were selected to predict prognosis in 
patients with SAH on the basis of the results of multi-vari-
able logistic regression using backward Wald selection. 
As ST depression and tall T wave formation do not occur 
simultaneously, they were considered one variable. The 
scoring systems were entered individually as continuous 
variables into the model with clinical variables, CT find-
ings and ECG abnormalities. In this study, we developed 
three simplified nomograms including age, ECG changes 
and each scoring system and compared the predictive 
performance of new nomograms with those of the WFNS 
scale, HH system and Fisher scale. The performance of 
the nomograms in predicting outcomes was validated with 
respect to discrimination and calibration. Nomogram 
predictive accuracy (discrimination) is measured via a 
concordance index (c-index), analogous to AUC, which 
quantifies the level of concordance between predicted 
probabilities and the actual chance of the event of interest 
occurring. A value of 0.5 indicates no predictive discrim-
ination, and a value of 1.0 indicates perfect separation of 
patients with different outcomes. The Delong method was 
used to compare the C-indexes of each model. Calibration 
of the nomogram determines how far the predicted prob-
abilities are from the observed outcome frequencies using 
graphic representations (calibration curve). A plot along 
the 45-degree line would indicate a perfect calibration 
model in which the predicted probabilities are identical to 
the actual outcomes. The calibration curves are presented 
as apparent and bias-corrected calibration plots using the 
bootstrapping methods with 200 re-samples. The predic-
tive accuracy and calibration of the new nomograms were 
then externally validated with data derived from another 
ED (validation set; n=141). A value of p<0.05 was consid-
ered statistically significant.
Figure 2 The newly developed nomograms. Nomograms for predicting 6 month prognosis among patients with subarachnoid 
haemorrhage incorporating World Federation of Neurosurgical Societies (WFNS) scale (A), Hunt and Hess (HH) system (B) 
and Fisher scale (C). The predicted probability (1/ (1+exp(-A))) of each nomogram is as follows: predicted Probability=1/
(1+exp(-A)), (a) where A=−6.4930 + 0.0666 * age +1.0802 * WFNS grade + 3.0820 * STD or tall T, (b) where A=−8.4664 + 0.0671 
* age +1.5685 * HH grade +2.8352 * STD or tall T, (c) where A=−9.4180 + 0.0557 * age +1.6794 * Fisher grade +3.6150 * STD or 
tall T. By calculating the total number of points and locating it on the total point scale, we can easily draw a straight line down to 
estimate the predicted prognosis. For example, if a 50-year-old patient had ST depression on initial ECG with a WFNS score of 
3, a final score of 160 could be attained as the sum of each corresponding score (39 points for age, 50 points for WFNS 3 and 
71 points for ST depression) and the predicted probability of poor prognosis was 95.9%. STD, ST depression.
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results
study population
A total of 665 patients with SAH were initially enrolled in 
the present study during the study period. Most patients 
(n=411; 61.8%) were excluded because they were 
referred from or to other hospitals. We also excluded 52 
patients for the following reasons: age <19 years (n=12), 
no initial ECG (n=3), cardiac arrest on arrival (n=6) and 
SAH due to trauma (n=31). Finally, 202 patients were 
included in the primary analysis (figure 1). The baseline 
characteristics and ECG changes related to prognosis are 
summarised in table 1. Of the 202 patients, 111 (54.9%) 
had a good outcome with a GOS of 4 or 5.
eCG changes of patients with sAh
Of the 202 patients, 79 (39.1%) had ECG changes, which 
included ST elevation in 17 (8.4%), ST depression in 31 
(15.3%), T wave inversion in 21 (10.4%) and tall T wave 
in 10 (5.0%) patients. ST depression and tall T waves were 
detected more often in patients with a poor outcome 
than in those with a good outcome (29 patients (31.9%) 
vs two patients (1.8%); p<0.001 and 9 patients (9.9%) 
vs. one patient (0.9%); p=0.006, respectively).The QTc 
of patients with a poor outcome was significantly longer 
than that of patients with a good outcome (479.1 (53.0) s 
vs 458.1 (39.1) s; p=0.002).
nomograms for the prediction of prognosis
In this study, we established three nomograms incor-
porating each scoring system (figure 2).The Harrell’s 
C-index for the new nomogram including the WFNS scale 
to predict prognosis of patients with SAH (0.912; 95% CI, 
0.871 to 0.954) was significantly higher than that of the 
WFNS scale (0.813; 95% CI, 0.758 to 0.868; p<0.001). In 
addition, the C-indexes of the two nomograms including 
the HH system and Fisher scale were greater than those of 
the HH system and Fisher scale (0.913 (0.872 to 0.955) vs 
0.826 (0.772 to 0.879); p<0.001 and 0.885 (0.839 to 0.931) 
vs 0.746 (0.687 to 0.805); p<0.001, respectively). There 
was no significant difference in the predictive accuracy of 
the three newly established models (p=0.350). The cali-
bration plots presented an excellent agreement between 
predicted and observed probabilities of the 6 month 
prognosis and exhibited a close approximation between 
the probabilities (figure 3).
external validation of the nomograms
The new nomograms were externally validated using 
the independent dataset (figure 1) listed in table 2. The 
Figure 3 Performance of the nomograms incorporating the World Federation of Neurosurgical Societies scale (A), Hunt and 
Hess system (B) and Fisher scale (C). Receiver-operating characteristic curves of the nomograms are on the top line. The 
discrimination ability of the newly developed nomograms was good, with an area under the receiver-operating characteristic 
curve (AUC) value of 0.912 (95% CI, 0.871 to 0.954), 0.913 (95% CI, 0.872 to 0.955) and 0.885 (95% CI, 0.839 to 0.931), 
respectively. The calibration curves are on the bottom line. All calibration plots (dotted lines) show close approximation to the 
logistic calibration (solid lines), indicating excellent agreement between the predicted and observed probabilities of the 6 month 
prognosis. HH, Hunt and Hess; STD, ST depression; WFNS, World Federation of Neurosurgical Societies.
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C-indexes of nomograms including the WFNS scale, HH 
systems and Fisher scale were 0.809 (0.735–0.884), 0.812 
(0.737–0.886) and 0.772 (0.691–0.852), respectively. The 
calibration plots presented an acceptable agreement in 
the external validation cohort between the nomogram 
prediction and actual observation (figure 4).
DIsCussIOn
In this study, we developed and externally validated 
new nomograms using three independent variables to 
determine the 6 month prognosis in patients with SAH 
admitted to the ED. The three independent variables 
were age, ECG changes, including ST depression or tall T 
wave formation, and conventional scoring systems, such 
as the WFNS scale, HH systems and Fisher scale. The new 
nomograms demonstrated a significantly higher predic-
tive accuracy than conventional scoring systems.
The association between ECG changes and prog-
nosis has been previously studied; however, the associa-
tion between abnormal ECG and prognosis prediction 
remains controversial. We previously investigated whether 
the ECG could be used to evaluate patient prognosis. 
The most frequent ECG change associated with SAH is 
QTc prolongation.12 17 20 22 In 2012, Huang et al investi-
gated whether early ECG abnormalities recorded in the 
ED were associated with in-hospital mortality among 
patients with SAH. QTc prolongation was found to be 
independently associated with in-hospital mortality.17 
Another study also demonstrated the association between 
in-hospital mortality and QTc prolongation.22 However, 
the underlying mechanism for this finding remains 
unclear. In our previous study, QTc prolongation was 
associated with poor prognosis and mortality (survivor vs. 
Table 2 Clinical characteristics of the external validation 
group
Good 
outcome
Poor 
outcome Total
P value(n=77) (n=64) (n=141)
Age (year) 53.2 (11.1) 59.6 (14.5) 56.2 (13.2) 0.04
ECG changes
  STD or tall T 13 (16.9%) 33 (51.6%) 46 (32.6%) <0.001
Scoring systems*
  WFNS scales 1 (1~1) 3 (1~4) 1 (1~4) <0.001
  HH system 2 (2~2) 3 (2~4) 2 (1~4) <0.001
  Fisher grade 3 (3~3) 4 (3~4) 3 (3~4) <0.001
Data are presented as frequencies (%) or mean (SD), unless 
otherwise indicated.
*Median (IQR).
HH, Hunt and Hess; STD, ST depression; WFNS, World Federation 
of Neurosurgical Societies.
Figure 4 External validation of the nomograms incorporating the World Federation of Neurosurgical Societies (WFNS) scale 
(A), Hunt and Hess system (HH) (B) and Fisher scale (C). Receiver operating characteristic curves of the nomograms are 
on the top line. The discrimination ability of newly developed nomograms was good, with an area under receiver-operating 
characteristic curve (AUC) value of 0.809 (95% CI, 0.735 to 0.884), 0.812 (95% CI, 0.737 to 0.886), and 0.772 (95% CI. 0.691 to 
0.852), respectively. The calibration curves are on the bottom line. The calibration plots presented good agreement between the 
nomogram prediction and actual observation. STD, ST depression.
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non-survivor; 464.9±46.4 ms vs. 486.0±47.5 ms, p=0.04). 
However, multi-variable logistic analysis revealed that QTc 
prolongation was not independently associated with poor 
prognosis in patients with SAH.20 Other ECG changes 
associated with poor prognosis in patients with SAH are 
ST depression and non-specific ST segment changes 
(NSSTC).17 A sudden increase in intracranial pressure 
compresses the brain, triggering a sympathetic discharge. 
This creates a relative ischaemic state of the myocardium 
and causes ischaemic changes on the ECG. ST depression 
and NSSTC were found to be significantly associated with 
mortality or poor neurologic outcome.17 22 Furthermore, 
the combination of tall T waves, tall P waves, large U waves 
and prolonged QT has been associated with increased 
mortality.23 In our study, ST depression or tall T waves 
were also independently associated with poor prognosis.
In addition to ECG changes, reports have suggested 
that other factors may be associated with prognosis 
among patients with SAH.8 11 24–26 In our study, patient 
age was significantly associated with prognosis. Age was 
found to be a major independent prognostic factor in 
many studies.24–26 This could be explained by the fact that 
the aged brain may have less ability to recover from initial 
bleeding. Increased initial bleeding among aged patients 
also explains the poor outcomes.24
Classification and scoring systems to predict the prognosis 
of patients with SAH have been developed since 1956. The 
most broadly used systems are the HH system and WFNS 
scale.7 The HH system divides disease status into five grades 
based on patient symptoms and level of consciousness.10 
Although this system is a good reflection of patient prog-
nosis, the demarcation between each grade is ambiguous 
because of less clearly defined scales of consciousness.7 To 
overcome this shortcoming, the WFNS scale uses the GCS 
as the prognostic predictor and the neurologic deficit was 
added to the differentiation between WFNS grades 2 and 
3. However, there was occasional overlap between grades 2 
and 3 and the predicted outcomes may not differ substan-
tially.27 28 To reduce the ambiguity between WFNS grades 
2 and 3, a modified WFNS scale was developed.9 However, 
the modified WFNS scale failed to show any significant 
prognostic differences between grades 3 and 4.23
The association between radiological findings and 
patient outcome has been previously reported.7 In 1980, 
Fisher et al developed a scale assigning a grade according 
to the pattern of blood demonstrated on the initial CT 
scan for the prediction of cerebral vasospasm after SAH.6 
Although it was designed to predict vasospasm, the predic-
tive value of patient outcome has also been reported. 
However, the Fisher scale was designed when radiolog-
ical technology resolution was only 10% of the current 
resolution. In the clinical context, it is uncommon for 
blood clots less than 1 mm in true thickness to occur in 
the subarachnoid space and to have no blood visible on 
the initial CT scan. Therefore, Fisher grades 1 and 2 were 
uncommon.7
Several advances, including the refinement of neurosur-
gical techniques, have taken place in SAH management 
since these scales were developed. Furthermore, reports 
found that the demarcation of the grades using these 
scales was ambiguous. To overcome these issues, we devel-
oped simple models by adding age and ECG changes to 
the existing models. The nomogram can generate an 
individual probability of a clinical event, such as mortality, 
by integrating prognostic variables.21 With this advantage, 
a nomogram is being utilised to predict disease prognosis 
in different fields. Our nomograms used only three prog-
nostic factors, such as existing scoring systems, age and 
ECG changes. The existing scoring systems are widely 
used. Age and ECG changes are easily and readily obtain-
able during the patient’s admission at the ED. Our nomo-
grams were the first approach to combine ECG changes 
and other prognostic factors in patients with SAH. This 
combination approach had more accurate predictive 
power than those of conventional scoring system alone, 
and there was excellent agreement between predicted 
and observed probabilities of 6 month prognosis.
Our study has several limitations. First, this study was a 
retrospective analysis; therefore, the results could differ 
from those of other centres, and the predictive probability 
could be overestimated more than in a prospective study. 
Second, we excluded patients referred from or to other 
hospitals, and this raises the possibility of selection bias. 
However, the patients were excluded because initial ECG 
could not be obtained or patients’ prognosis could not 
be evaluated. Finally, interval from the onset of symptoms 
to arrival at the ED differs for each patient. ECG changes 
may not have been visible when patients presented late 
to the ED. We need to assess the applicability of our new 
nomograms in future prospective studies and validate 
them in a multi-centre study.
COnClusIOns
We developed new nomograms using only three indepen-
dent variables: ECG changes including ST depression or 
tall T wave formation, age and widely used conventional 
scoring systems, such as the WFNS scale, HH systems 
and Fisher scale. Our new nomograms are valuable in 
predicting the 6 month prognosis of patients with SAH 
at an early stage after ED admission. Our new models are 
superior to the WFNS scale, HH systems and Fisher scale 
in predicting prognosis and are readily available.
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